BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27919007)

  • 1. Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture.
    Hlavica P
    J Inorg Biochem; 2017 Feb; 167():100-115. PubMed ID: 27919007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key regulators in the architecture of substrate access/egress channels in mammalian cytochromes P450 governing flexibility in substrate oxyfunctionalization.
    Hlavica P
    J Inorg Biochem; 2023 Apr; 241():112150. PubMed ID: 36731371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative biotransformation of fatty acids by cytochromes P450: predicted key structural elements orchestrating substrate specificity, regioselectivity and catalytic efficiency.
    Hlavica P; Lehnerer M
    Curr Drug Metab; 2010 Jan; 11(1):85-104. PubMed ID: 20302567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of structural features in fungal cytochromes P450 predicted to rule catalytic diversification.
    Hlavica P
    Biochim Biophys Acta; 2013 Jan; 1834(1):205-20. PubMed ID: 23009807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insect cytochromes P450: topology of structural elements predicted to govern catalytic versatility.
    Hlavica P
    J Inorg Biochem; 2011 Oct; 105(10):1354-64. PubMed ID: 21930014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
    Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
    Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction of nitrogenous organic bases with cytochrome P450: a critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines.
    Hlavica P
    Biochim Biophys Acta; 2006 Apr; 1764(4):645-70. PubMed ID: 16503427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation.
    Polic V; Auclair K
    Bioconjug Chem; 2017 Apr; 28(4):885-889. PubMed ID: 28339191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of substrate motion in cytochrome P450 3A4-mediated xylene oxidation.
    Childers WK; Harrelson JP
    Biochemistry; 2014 Feb; 53(6):1018-28. PubMed ID: 24476063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
    Atkins WM
    Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives.
    Shou M; Mei Q; Ettore MW; Dai R; Baillie TA; Rushmore TH
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):845-53. PubMed ID: 10359672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from "distributive catalysis".
    Atkins WM; Lu WD; Cook DL
    J Biol Chem; 2002 Sep; 277(36):33258-66. PubMed ID: 12082118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
    Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.
    Sevrioukova IF
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
    Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
    Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
    Sevrioukova IF; Poulos TL
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.
    Denisov IG; Grinkova YV; Nandigrami P; Shekhar M; Tajkhorshid E; Sligar SG
    Biochemistry; 2019 Mar; 58(10):1411-1422. PubMed ID: 30785734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen.
    Shahrokh K; Cheatham TE; Yost GS
    Biochim Biophys Acta; 2012 Oct; 1820(10):1605-17. PubMed ID: 22677141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.